Viewing Study NCT06295432


Ignite Creation Date: 2025-12-24 @ 9:58 PM
Ignite Modification Date: 2025-12-30 @ 1:19 AM
Study NCT ID: NCT06295432
Status: RECRUITING
Last Update Posted: 2025-07-18
First Post: 2024-02-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Clinical Trial of DZD9008 in Combination With AZD4205 in Standard Treatment Failed NSCLC Patients With EGFR Mutations (WU-KONG21)
Sponsor: Dizal Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module